Financial Survey: Envoy Medical (NASDAQ:COCH) & LogicMark (NASDAQ:LGMK)

LogicMark (NASDAQ:LGMK) and Envoy Medical (NASDAQ:COCH) are both small-cap industrial products companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation and institutional ownership.

Valuation & Earnings

This table compares LogicMark and Envoy Medical”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LogicMark	$9.93 million	0.07	-$14.55 million	($9.84)	-0.01
Envoy Medical	$320,000.00	127.40	-$29.91 million	N/A	N/A

LogicMark has higher revenue and earnings than Envoy Medical.

Profitability

This table compares LogicMark and Envoy Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
LogicMark	-146.14%	-104.48%	-79.87%
Envoy Medical	-4,564.57%	N/A	-125.15%

Analyst Recommendations

This is a breakdown of recent recommendations for LogicMark and Envoy Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LogicMark	0	0	0	0	0.00
Envoy Medical	0	0	4	0	3.00

Envoy Medical has a consensus price target of $7.92, suggesting a potential upside of 280.61%. Given Envoy Medical’s stronger consensus rating and higher possible upside, analysts clearly believe Envoy Medical is more favorable than LogicMark.

Insider & Institutional Ownership

7.9% of LogicMark shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 3.5% of LogicMark shares are owned by company insiders. Comparatively, 60.5% of Envoy Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Volatility and Risk

LogicMark has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.38, indicating that its share price is 138% more volatile than the S&P 500.

Summary

Envoy Medical beats LogicMark on 8 of the 12 factors compared between the two stocks.

About LogicMark

LogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company’s devices provide people with the ability to receive care at home and age independently and to check, manage, and monitor a loved one’s health and safety remotely. It also manufactures and distributes non-monitored and monitored personal emergency response systems, which are offered through the United States Veterans Health Administration (VHA), direct-to-consumers, healthcare durable medical equipment dealers and distributors, monitored security dealers and distributors, and its ecommerce website logicmark.com and Amazon.com. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.